SAVIENT PHARMACEUTICALS ANNOUNCES AN EXCLUSIVE MARKETING COLLABORATION IN GERMANY FOR SOLTAMOX

Savient Pharmaceuticals, an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs has announced the exclusive marketing agreement between their wholly owned subsidiary, Rosemont Pharmaceuticals ("Rosemont") and O.R.C.A.PHARM GmbH to market and distribute Soltamox (tamoxifen oral liquid solution) in Germany.

Yahoo News (http://biz.yahoo.com/bw/050106/65191_1.html)